Exploring anti-SARS-CoV-2 natural products: dual-viral target inhibition by delphinidin and the anti-coronaviral efficacy of deapio platycodin D
Open Access
- 13 June 2025
- journal article
- research article
- Published by Springer Nature in Natural Products and Bioprospecting
- Vol. 15 (1) , 1-22
Abstract
Qingfei Paidu decoction (QFPDD) has been extensively used in clinical treatments during the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) epidemic. SARS-CoV-2 primarily invades host cells via its spike (S) protein binding to the angiotensin-converting enzyme 2 (ACE2) on the cell membrane, mediating viral-host membrane fusion. Blocking viral entry is a crucial step in preventing infection, with the interaction between the S receptor binding domain (S-RBD) and ACE2 being a key antiviral target. Given that SARS-CoV-2 predominantly affects the respiratory system and approximately 25% of patients suffering from corona virus disease 2019 (COVID-19) with gastrointestinal symptoms, we are committed to identifying more active ingredients in QFPDD that target the respiratory and gastrointestinal tracts of COVID-19 patients. Among medicinal plants, ephedra and liquorice derived from QFPDD, along with two other Chinese herbs, Platycodon grandiflorum and Radix Rhei Et Rhizome (rhubarb), have garnered our interest. These herbs have historically been used in traditional Chinese medicine (TCM) for treating infectious diseases with respiratory and digestive symptoms. Here, we established a library containing all components of the four individual herbs gathered from the Traditional Chinese Medicine Systems Pharmacology Database and Analysis Platform (TCMSP) and performed structure-based virtual screening to identify potential ACE2/S-RBD inhibitors. Subsequently, we selected 10 ingredients from the top 30 candidates and evaluated their activities using a pseudovirus neutralization assay. Delphinidin and deapio platycodin D (DPD) showed significant antiviral potential with half-maximal inhibitory concentration (IC50) values of 45.35 µM and 1.38 µM, respectively. Furthermore, delphinidin also inhibited the 3-chymotrypsin-like protease (3CLpro), indicating its dual-viral target inhibitory potential. Notably, DPD effectively suppressed HCoV-229E replication in BEL-7402 cells. This study not only provides a strategy for rapid identifying antiviral agents from TCM in anticipation of future pandemics but also offers theoretical and experimental evidence to support for the clinical use of QFPDD. Graphical AbstractKeywords
Funding Information
- National Natural Science Foundation of China (82141203)
- National Key Research and Development Program of China (2023YFC3503400)
- National Key Research and Development Program of China (2022YFC3502000)
- Shanghai Municipal Science and Technology Major Project (ZD2021CY001)
- SIMM-SHUTCM Traditional Chinese Medicine Innovation Joint Research Program (E2G805H)
This publication has 65 references indexed in Scilit:
- Hepatitis C Virus (HCV) and the Role of Phytochemicals in the Anti-Viral Effects of Different Medicinal Plants Against Infection2023
- Protein palmitoylation in cancer: molecular functions and therapeutic potentialMolecular Oncology, 2022
- Targeting intestinal flora and its metabolism to explore the laxative effects of rhubarbApplied Microbiology and Biotechnology, 2022
- Pseudoephedrine and its derivatives antagonize wild and mutated severe acute respiratory syndrome‐CoV‐2 viruses through blocking virus invasion and antiinflammatory effectPhytotherapy Research, 2021
- A review on phytochemicals, pharmacological activities, drug interactions, and associated toxicities of licorice (Glycyrrhizasp.)Food Frontiers, 2021
- The Yin and Yang of traditional Chinese and Western medicineMedicinal Research Reviews, 2021
- Glycyrrhizin: An old weapon against a novel coronavirusPhytotherapy Research, 2020
- Respiratory Conditions2015
- Delphinidin, an anthocyanidin in pigmented fruits and vegetables, induces apoptosis and cell cycle arrest in human colon cancer HCT116 cellsMolecular Carcinogenesis, 2008
- Review of Pharmacological Effects of Glycyrrhiza sp. and its Bioactive CompoundsPhytotherapy Research, 2008